SCHEMBL3662784

SCHEMBL3662784

C=C(c1cccc(OC)c1)c1ccc2[nH]c3nccc(Cl)c3c2c1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 7/20 0.47
PTK6 Q13882 6/20 0.47
EGFR P00533 2/20 0.45
IGF1R P08069 2/20 0.45
ALK Q9UM73 2/20 0.41
CHUK O15111 1/20 0.40
ICOSLG O75144 1/20 0.40
ICOS Q9Y6W8 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KCNQ3 O43525 1/20 0.39
KCNQ2 O43526 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
AURKA O14965 1/20 0.38
AURKB Q96GD4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL676374 0.88 ERBB2 (0.47) ERBB2PTK6EGFRIGF1RALK
SCHEMBL3669225 0.85 AURKA (0.47) ERBB2PTK6EGFRIGF1RALK
SCHEMBL676282 0.81 MAPT (0.45) CHUKICOSLGICOSMAPTSMN1; SMN2
SCHEMBL3666125 0.79 KCNQ3 (0.42) CHUKICOSLGICOSMAPTSMN1; SMN2
SCHEMBL675413 0.76 NPC1 (0.39) EGFRMAPTSMN1; SMN2MEN1NPC1
SCHEMBL676840 0.76 AURKA (0.42) ERBB2PTK6ALKNPC1RAB9A
SCHEMBL674216 0.75 ERBB2 (0.48) ERBB2PTK6ALKMEN1NPC1
SCHEMBL3668987 0.74 ALK (0.61) ERBB2PTK6ALK
SCHEMBL676137 0.73 AURKA (0.50) ERBB2PTK6ALKSMN1; SMN2RAB9A
SCHEMBL674994 0.72 ERBB2 (0.50) ERBB2PTK6ALKAURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895744-B2 Alfa-carboline inhibitors of NPM-ALK, RET, and Bcr-Abl UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA (IT) 2014-11-25 US disclosed
EP-2161271-A1 Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl Università Degli Studi Di Milano - Bicocca (IT) 2010-03-10 EP disclosed